Kinaxis Inc. (TSE:KXS – Get Free Report) Director John Ernest Sicard sold 24,147 shares of Kinaxis stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of C$167.91, for a total transaction of C$4,054,585.55.
Kinaxis Stock Down 0.7 %
TSE KXS traded down C$1.22 during trading on Friday, hitting C$165.15. 119,810 shares of the company traded hands, compared to its average volume of 66,860. The company has a market capitalization of C$4.66 billion, a P/E ratio of 165.15, a PEG ratio of 3.60 and a beta of 0.78. The business has a fifty day simple moving average of C$159.29 and a 200 day simple moving average of C$155.52. Kinaxis Inc. has a 12 month low of C$132.93 and a 12 month high of C$174.25. The company has a current ratio of 1.90, a quick ratio of 2.29 and a debt-to-equity ratio of 12.40.
Kinaxis (TSE:KXS – Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported C$0.47 earnings per share for the quarter, beating analysts’ consensus estimates of C$0.43 by C$0.04. The business had revenue of C$165.79 million for the quarter, compared to the consensus estimate of C$170.56 million. Kinaxis had a return on equity of 4.87% and a net margin of 4.59%. As a group, sell-side analysts predict that Kinaxis Inc. will post 4.2526231 EPS for the current year.
Analyst Ratings Changes
Check Out Our Latest Stock Report on Kinaxis
Kinaxis Company Profile
Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services.
See Also
- Five stocks we like better than Kinaxis
- What is the Shanghai Stock Exchange Composite Index?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- What Is WallStreetBets and What Stocks Are They Targeting?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Earnings Per Share Calculator: How to Calculate EPS
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.